GenixPharmaceucticals Corporation

Research GenixPharmaceucticals Corporation (GENX) on Bullrun: market cap CAD 918.36K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGENX
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyCAD
• Market capCAD 918.36K
• Financial periodQ1 2026
• Net income-CAD 51.64K
• Free cash flow-CAD 30.25K

Valuation Snapshot

latest market cap is CAD 918.36K.

About GenixPharmaceucticals Corporation

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product;

Frequently asked questions

What is GenixPharmaceucticals Corporation's market cap?

GenixPharmaceucticals Corporation's market capitalization is CAD 918.36K.

What does GenixPharmaceucticals Corporation do?

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada.